AngioDynamics, Inc. (ANGO) Tops Q2 EPS by 7c, Boosts Low End of FY14 Revenue Guidance
AngioDynamics, Inc. (NASDAQ: ANGO) reported Q2 EPS of $0.14, $0.07 better than the analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
